Aspen Aerogels Q3 revenue $73M (-38% YoY); lowers FY2025 outlook on slower EV production

ASPEN AEROGELS INC

2025-Q3 EPS reported -$3.85 revenue$229,764,000

Revenue $73.0M vs $117.3M in Q3 2024 (down 38%); net loss $6.3M improved from $13.0M loss last year.
Adjusted EBITDA fell to $6.3M from $25.4M in prior year; adjusted EPS loss $0.06 vs $0.17 loss.
Cites lower near-term EV production in North America as reason for updated full-year 2025 outlook.
PyroThin award from a major EU OEM; LNG and subsea project opportunities expected to drive growth in 2026.
Restructuring and impairment charges of $1.6M included in Q3 net loss.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.